Live Breaking News & Updates on Opiant Pharmaceuticals Says Based On

Company s 52-week low was at $6.79
Price action over last quarter: down 6.20%
Company Overview
Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. The company s pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD) and Acute Cannabinoid Overdose (ACO). The majority of the revenue is generated in the form of Royalty and licensing.
  ....

Company Overview , Opiant Pharmaceuticals Inc , Opiant Pharmaceuticals Says Based On , Opiant Pharmaceuticals , Continues To See , Pharmaceuticals Inc , Nasal Spray , Opioid Overdose Reversal , Alcohol Use Disorder , Opioid Use Disorder , Acute Cannabinoid Overdose , நிறுவனம் ஓவர்‌வ்யூ , மருந்துகள் இன்க் , நாசி தெளிப்பு , ஓபியாய்டு ஓவர்‌டோஸ் தலைகீழ் , ஆல்கஹால் பயன்பாடு கோளாறு , ஓபியாய்டு பயன்பாடு கோளாறு , எடுப்போசை கன்னாபினாய்டு ஓவர்‌டோஸ் ,